DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Elixophyllin Sr is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in ELIXOPHYLLIN SR is theophylline. There are thirty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the theophylline profile page.
A generic version of ELIXOPHYLLIN SR was approved as theophylline by RHODES PHARMS on September 1st, 1982.
Recent Clinical Trials for ELIXOPHYLLIN SR
Identify potential brand extensions & 505(b)(2) entrants
|Vanderbilt University Medical Center||Phase 2|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Forest Labs||ELIXOPHYLLIN SR||theophylline||CAPSULE, EXTENDED RELEASE;ORAL||086826-001||Jan 29, 1985||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|Forest Labs||ELIXOPHYLLIN SR||theophylline||CAPSULE, EXTENDED RELEASE;ORAL||086826-002||Jan 29, 1985||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|